abstract |
The present invention describes crystalline polymorphs of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid. The invention also provides pharmaceutical compositions and the use of such compounds, compound forms and compositions for the treatment of a variety of diseases and conditions. |